Use of anticoagulants in elderly patients: practical recommendations

Código QR

Use of anticoagulants in elderly patients: practical recommendations

Helia Robert-Ebadi, Grégoire Le Gal, Marc RighiniDivision of Angiology and Hemostasis (HRE, MR), Department of Internal Medicine, Geneva University Hospital and Faculty of Medicine, Geneva, Switzerland, and Department of Internal Medicine and Chest Diseases, EA 3878 (GETBO), Brest Univers...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Helia Robert-Ebadi, Grégoire Le Gal, Marc Righini
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2009
Materias:	anticoagulation elderly patients venous thromboembolism hemorrhagic risk atrial fibrillation thrombin inhibitors factor Xa inhibitor Geriatrics RC952-954.6
Acceso en línea:	https://doaj.org/article/2eed0b8b8681471e8d772cac4a0b6aa2
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Avances en la prevención de eventos tromboembólicos en pacientes con fibrilación auricular
por: Montagna M,Rodrigo, et al.
Publicado: (2007)

Anticoagulation for Stroke Prevention after Restoration of Haemostasis with Emicizumab in Acquired Haemophilia A
por: Kadhim Al-Banaa, et al.
Publicado: (2021)

Hospitalized frail elderly patients – atrial fibrillation, anticoagulation and 12 months’ outcomes
por: Ekerstad N, et al.
Publicado: (2018)

Evaluación de la anticoagulación con rivaroxaban, en pacientes con fibrilación auricular no valvular de reciente diagnóstico
por: Neira,Víctor, et al.
Publicado: (2016)

Efectividad y seguridad del tratamiento anticoagulante con acenocumarol en fibrilación auricular no valvular
por: Castro,Constanza, et al.
Publicado: (2017)

Profilaxis de enfermedad tromboembólica en pacientes hospitalizados con patología médica, estrechando la brecha entre las guías y la práctica clínica
por: Aizman,Andrés, et al.
Publicado: (2011)

Anticoagulation after Spontaneous Intraparenchymal Hemorrhage in Patients with Mechanical Heart Valves and Concomitant Atrial Fibrillation
por: Jennifer H. Kang, et al.
Publicado: (2021)

Antithrombotic Therapy in Elderly Patients with Atrial Fibrillation: The State of the Problem in the Real Clinical Practice of a Family Medicine Doctor
por: Bazira Kanat кyzy, et al.
Publicado: (2021)

Antithrombotic therapy in very elderly patients with atrial fibrillation: Is it enough to assess thromboembolic risk?
por: Yutao Guo, et al.
Publicado: (2010)

Equivalent VTE rates after total joint arthroplasty using thromboprophylaxis with aspirin versus potent anticoagulants: retrospective analysis of 4562 cases across a diverse healthcare system
por: Chelsea Matzko, et al.
Publicado: (2021)

Oral anticoagulation to reduce risk of stroke in patients with atrial fibrillation: current and future therapies
por: Amin A
Publicado: (2013)

Severe gastrointestinal bleeding in patients with atrial fibrillation receiving oral anticoagulants (based on REGistry of long-term AnTithrombotic TherApy – REGATTA)
por: Ekaterina S. Kropacheva, et al.
Publicado: (2021)

Características basales, manejo de terapias antitrombóticas y pronóstico de pacientes chilenos con FA no valvular. Lecciones del Registro GARFIELD AF en Chile
por: Corbalán,Ramón, et al.
Publicado: (2017)

ANTICOAGULATION CONTROL AMONG PATIENTS WITH ATRIAL FIBRILLATION
por: Amer Rauf, et al.
Publicado: (2020)

Using non-vitamin K oral anticoagulants in specific patient populations: a study of Korean cases
por: Cho IY
Publicado: (2019)

The effect of apixaban on the pharmacokinetics of digoxin and atenolol in healthy subjects
por: Frost C, et al.
Publicado: (2017)

Patients with venous thromboembolism after spontaneous intracerebral hemorrhage: a review
por: Qiyan Cai, et al.
Publicado: (2021)

Long-term effect of anticoagulation following left atrial appendage occlusion with the LARIAT device in patients with nonvalvular atrial fibrillation: impact on thromboembolism, bleeding and mortality. Real life data
por: Radosław Litwinowicz, et al.
Publicado: (2020)

Impacto de la atención farmacéutica en la calidad del tratamiento con acenocumarol en pacientes con fibrilación auricular
por: Leal,Bryan, et al.
Publicado: (2021)

Characteristics of warfarin under-prescription in older adults with atrial fibrillation
por: Sana Rashid, et al.
Publicado: (2021)

Claims‐Based Score for the Prediction of Bleeding in a Contemporary Cohort of Patients Receiving Oral Anticoagulation for Venous Thromboembolism
por: Alvaro Alonso, et al.
Publicado: (2021)

Real life behaviour of direct oral anticoagulants in patients with nonvalvular atrial fibrillation and morbid obesity
por: Begoña Navarro-Almenzar, et al.
Publicado: (2021)

Anticoagulation in Patients with Liver Cirrhosis (Literature Review)
por: E. S. Eniseeva
Publicado: (2019)

Rivaroxaban triggered multifocal intratumoral hemorrhage of the cabozantinib-treated diffuse brain metastases: A case report and review of literature
por: Chen Luyue, et al.
Publicado: (2021)

Hospitalizaciones asociadas al diagnóstico de fibrilación auricular en Chile: Tendencia creciente en la última década
por: Ortiz,Mario, et al.
Publicado: (2011)

Antithrombotic therapy in elderly patients with non-valvular atrial fibrillation: a pilot study
por: Xiang W, et al.
Publicado: (2015)

Does Warfarin or Rivaroxaban at Low Anticoagulation Intensity Provide a Survival Benefit to Asian Patients With Atrial Fibrillation?
por: Dong Lin, et al.
Publicado: (2021)

Perioperative interruption of direct oral anticoagulants and vitamin K antagonists in patients with atrial fibrillation: A comparative analysis
por: Joseph R. Shaw, et al.
Publicado: (2020)

The current approach of atrial fibrillation management
por: Anish Amin, et al.
Publicado: (2016)

Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study
por: Gilda Denise Zielinski, et al.
Publicado: (2020)

Patient characteristics, adherence, and costs of oral anticoagulation therapy in non-valvular atrial fibrillation using the Dubai Real-World Claims Database
por: Moutaz El Kadri, et al.
Publicado: (2021)

Association of anticoagulant-related bleeding events with cancer detection in atrial fibrillation: A systematic review and meta-analysis
por: Anastasios Papanastasiou, et al.
Publicado: (2021)

Carotid Artery Stenting in Patients with Atrial Fibrillation: Direct Oral Anticoagulants, Brief Double Antiplatelets, and Testing Strategy
por: José E. Cohen, et al.
Publicado: (2021)

Low Dose of Direct Oral Anticoagulants after Left Atrial Appendage Occlusion
por: Pedro Luis Cepas-Guillen, et al.
Publicado: (2021)

Complications at usage of the new anticoagulant therapy in elderly patients
por: Trailov Dunja, et al.
Publicado: (2021)

Current state of treatment for lower extremity acute deep venous thrombosis (a literature review)
por: A. O. Nykonenko, et al.
Publicado: (2021)

Risk scores and geriatric profile: can they really help us in anticoagulation decision making among older patients suffering from atrial fibrillation?
por: Maes F, et al.
Publicado: (2014)

Mean platelet volume as a prognostic factor for venous thromboembolic disease
por: Díaz,Juan Manuel, et al.
Publicado: (2019)

Effect of proton pump inhibitor use on Helicobacter pylori positivity and atrial fibrillation
por: Atay K, et al.
Publicado: (2015)

Low Prevalence of Thrombosis Prophylaxis Dose Adjustments Highlights Implications for Patient Safety
por: W. Anthony Hawkins, et al.
Publicado: (2021)